St. Augustin and Erlangen, Germany, June 24^th, 2007 — BioSolveIT GmbH and Molecular Networks GmbH today announced that they are intensifying their collaboration and marketing activities on the US-American and Canadian market. The two companies have signed an agreement whereby BioSolveIT, respected worldwide for its docking tool FlexX, will also market Molecular Networks' products such as CORINA – the industry benchmark for 3D structure generation – in North America. Effective immediately, BioSolveIT's US sales representative Dr. Marguerita Lim-Wilby will act as the point person for any product and license inquiries for both companies.

"Both our companies have a long-standing record of successful collaborations. Not only is it a logical next step, but also a great pleasure to intensify our relationship and better coordinate our marketing efforts for the benefit of our end-user customers", says Dr. Christian Lemmen, CEO of BioSolveIT. "There is a great deal of synergy between the software portfolios of our two companies. For example, ring conformers can be computed seamlessly during a FlexX docking calculation using CORINA. Now our customers can be served with these products from a single source." Prof. Johann Gasteiger, CEO of Molecular Networks and world-renowned for his contributions to chemoinformatics, adds: "Having a direct representative in the USA will allow us to better service our valued customers in North America and to respond more rapidly to their needs. I am very happy about this development."

Molecular Networks and BioSolveIT will have a joint booth together with Vienna-based Inte:Ligand GmbH at the ACS Fall Meeting & Exposition in Boston, MA from August 19^th-23^rd, 2007.